drugset / Trial / NCT00330577

24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients

NCT00330577

Phase 4 Completed 30 enrolled Aristotle University Of Thessaloniki
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to compare the short-term mean 24-hour intraocular pressure control, 24-hour blood pressure effect and safety of Latanoprost/Timolol fixed combination given once in the evening with placebo once in the morning versus timolol maleate 0.5% given twice daily in patients with ocular hypertension and primary open-angle glaucoma.

Timeline

Start
2006-04
Primary completion
2007-04
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Timolol Other / unclassified 0.5 %
Subject latanoprost/timolol Unknown